Del-desiran (AOC 1001) clinical trials

Global Open-Label Extension Study of Del-desiran for the Treatment of DM1

This study is an extension of previous research looking at a new medicine called del-desiran for Myotonic Dystrophy Type 1 (DM1). It aims to check its long-term safety and how well it works over several years.